TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20182421

Group type: EXPERIMENTAL
Intervention: Metabolic profiling using LC-MS on predose urine samples
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Oral administration of tacrolimus
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Partial least-squares (PLS) modeling
Number of subjects: 29
Study: 17959594

Group type: EXPERIMENTAL
Intervention: Young-isoflurane group
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Young-sevoflurane group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Elderly-isoflurane group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Elderly-sevoflurane group
Number of subjects: 60
Study: 16389742

Group type: EXPERIMENTAL
Intervention: Antiarrhythmic drug therapy
Number of subjects: 230
Study: 10926129

Group type: EXPERIMENTAL
Intervention: HIV prevention intervention
Number of subjects: 46

Group type: COMPARATOR
Intervention: Health promotion control
Number of subjects: 46
Study: 9052903

Group type: EXPERIMENTAL
Intervention: Xanomeline (oral formulation)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Xanomeline (first dose)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Xanomeline
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Methscopolamine
Number of subjects: 14
Study: 8306902

Group type: EXPERIMENTAL
Intervention: Hydroflumethiazide (HFM) 50mg daily
Number of subjects: 60

Group type: COMPARATOR
Intervention: Propranolol 80mg daily
Number of subjects: 60

Group type: COMPARATOR
Intervention: Propranolol 160mg daily (after 4 weeks)
Number of subjects: 60
Study: 3552225

Group type: EXPERIMENTAL
Intervention: Fiorinal with Codeine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fiorinal alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Codeine alone
Number of subjects: 0
Study: 30893577

Group type: EXPERIMENTAL
Intervention: MRA therapy (intravenous bolus of potassium canrenoate followed by oral spironolactone for 3 months)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo (matching placebo for 3 months)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: MRA therapy
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study: 29183291

Group type: EXPERIMENTAL
Intervention: Hockey Fans in Training (Hockey FIT) program, 90-minute weekly sessions for 12 weeks followed by a 40-week minimally-supported phase.
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Hockey FIT program
Number of subjects: 80
Study: 26085531

Group type: EXPERIMENTAL
Intervention: Twenty-four-hour group (received perioperative antibiotics for twenty-four hours)
Number of subjects: 314

Group type: COMPARATOR
Intervention: Drain-duration group (received antibiotics for the duration that the drain was in place)
Number of subjects: 314
Study: 23748182

Group type: EXPERIMENTAL
Intervention: Mobile phone-assisted personal interviews (MPAPI)
Number of subjects: 512
Study: 21593349

Group type: EXPERIMENTAL
Intervention: Conjugated linoleic acid (CLA) supplementation (50:50 mixture of trans 10, cis 12 and cis 9, trans 11 CLA)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Conjugated linoleic acid (CLA) supplementation (c9, t11 isomer:c9, t11 CLA)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Safflower oil (control)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Conjugated linoleic acid (CLA) supplementation
Number of subjects: 27
Study: 19369098

Group type: EXPERIMENTAL
Intervention: Single‐cone ProTaper gutta‐percha with AH‐26
Number of subjects: 70

Group type: COMPARATOR
Intervention: Lateral compaction technique with AH‐26
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Single‐cone ProTaper gutta‐percha with Apexit
Number of subjects: 70

Group type: COMPARATOR
Intervention: Lateral compaction technique with Apexit
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Single‐cone ProTaper gutta‐percha with Sealite‐Ultra
Number of subjects: 70

Group type: COMPARATOR
Intervention: Lateral compaction technique with Sealite‐Ultra
Number of subjects: 70
Study: 16965910

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide and cisplatin (CP)
Number of subjects: 169
Study: 15218999

Group type: EXPERIMENTAL
Intervention: BA+ICS (0.2 mg salbutamol t.i.d. and 0.2 mg budesonide t.i.d.)
Number of subjects: 54

Group type: COMPARATOR
Intervention: BA+PL (placebo t.i.d.)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: BA+ICS
Number of subjects: 54

Group type: COMPARATOR
Intervention: BA+PL
Number of subjects: 54
Study: 10899363

Group type: EXPERIMENTAL
Intervention: d-amphetamine (AMPH; 15 mg oral)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 9270499

Group type: EXPERIMENTAL
Intervention: Newer antimicrobial agents (third- and fourth-generation cephalosporins, β-lactam, β-lactamase inhibitor combination agents, monobactams, carbapenems, macrolides, fluoroquinolones)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Older antimicrobial agents
Number of subjects: 0
Study: 8112367

Group type: EXPERIMENTAL
Intervention: Zidovudine
Number of subjects: 36
Study: 3089942

Group type: EXPERIMENTAL
Intervention: Oral penicillin V‐K (100,000 U/kg/day every 6 h)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 29329233

Group type: EXPERIMENTAL
Intervention: Hydrolyzed whey-protein (30 kcal)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Hydrolyzed whey-protein (90 kcal)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Hydrolyzed whey-protein (180 kcal)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline control (0 kcal)
Number of subjects: 20
Study: 29932415

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) injection (2 mL)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Procaine injection
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) injection
Number of subjects: 60
Study: 26149510

Group type: EXPERIMENTAL
Intervention: ADHD medications (stimulant or nonstimulant)
Number of subjects: 48

Group type: COMPARATOR
Intervention: No ADHD medications (control group)
Number of subjects: 48
Study: 23086673

Group type: EXPERIMENTAL
Intervention: Prophylactic intra-aortic balloon counterpulsation (IABC)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Conventional hypervolemic therapy (HT)
Number of subjects: 71
Study: 21354549

Group type: EXPERIMENTAL
Intervention: Prior preeclampsia
Number of subjects: 369

Group type: COMPARATOR
Intervention: No prior preeclampsia
Number of subjects: 369
Study: 18298238

Group type: EXPERIMENTAL
Intervention: Prolonged abstainers
Number of subjects: 21

Group type: COMPARATOR
Intervention: Nonabstainers
Number of subjects: 21
Study: 16575034

Group type: EXPERIMENTAL
Intervention: Midazolam (0.05 mg x kg(‐1))
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Isoflurane (1.1% end‐tidal)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Aminophylline (3 mg.kg(‐1))
Number of subjects: 36
Study: 15198411

Group type: EXPERIMENTAL
Intervention: ondansetron 4 mg
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: dexamethasone 8 mg
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: ondansetron 4 mg plus dexamethasone 8 mg
Number of subjects: 160

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: ondansetron with dexamethasone
Number of subjects: 160
Study: 11108899

Group type: EXPERIMENTAL
Intervention: High trans diet (trans alpha-linolenic acid providing 0.6% of energy)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Low trans diet
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: High trans diet
Number of subjects: 88
Study: 7993004

Group type: EXPERIMENTAL
Intervention: Tubed radial forearm free flap reconstruction with Blom‐Singer prosthesis
Number of subjects: 11

Group type: COMPARATOR
Intervention: Standard pharyngeal closures
Number of subjects: 11
Study: 3052571

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Multiple injections (MI)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Conventional insulin treatment (CIT)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: CSII and MI (combined outcome)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: CSII and MI (compared to non-cotton-wool spots)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: CSII and MI (intensified treatment)
Number of subjects: 45
Study: 31122650

Group type: EXPERIMENTAL
Intervention: Pre-learning propranolol (40 mg)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Post-learning propranolol (40 mg)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Pre-encoding propranolol (40 mg) in women
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 31326732

Group type: EXPERIMENTAL
Intervention: Bi-parietal stimulation
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Bi-frontal stimulation
Number of subjects: 11

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 11
Study: 28207655

Group type: EXPERIMENTAL
Intervention: Ultra-low radiation imaging (ULRI) with image enhancement
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard-dose C-arm fluoroscopy
Number of subjects: 24
Study: 26387859

Group type: EXPERIMENTAL
Intervention: Upper thoracic spine manipulation
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 23624059

Group type: EXPERIMENTAL
Intervention: Cold pressor stress (CPS) during reconsolidation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral source of glucose (juice) during reconsolidation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diet juice (control)
Number of subjects: 0
Study: 21542913

Group type: EXPERIMENTAL
Intervention: Structured group education based on psychological theories and current evidence
Number of subjects: 82

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 82
Study: 19023522

Group type: EXPERIMENTAL
Intervention: Heparin used in 26% of patients
Number of subjects: 624

Group type: EXPERIMENTAL
Intervention: Educational sessions and risk stratification guidelines
Number of subjects: 624
Study: 17442032

Group type: EXPERIMENTAL
Intervention: Home visiting programme by experienced home nurses (8 visits over 18 months)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Home visiting programme by experienced home nurses
Number of subjects: 160
Study: 14996776

Group type: EXPERIMENTAL
Intervention: Atorvastatin (80 mg)
Number of subjects: 654

Group type: COMPARATOR
Intervention: Pravastatin (40 mg)
Number of subjects: 654
Study: 11475557

Group type: COMPARATOR
Intervention: MIP-1 alpha in chronic bronchitis patients
Number of subjects: 40

Group type: COMPARATOR
Intervention: MIP-1 beta in chronic obstructive pulmonary disease patients
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Correlation of MIP-1 beta with eosinophils in chronic bronchitis
Number of subjects: 40
Study: 9602592

Group type: EXPERIMENTAL
Intervention: Xenon anaesthesia (MAC = 71%)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Sevoflurane anaesthesia (MAC = 2%)
Number of subjects: 27
Study: 7594429

Group type: EXPERIMENTAL
Intervention: Combination of amlodipine and doxazosin (study A)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Combination of amlodipine and enalapril (study B)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Amlodipine alone
Number of subjects: 24

Group type: COMPARATOR
Intervention: Doxazosin alone (study A)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Enalapril alone (study B)
Number of subjects: 24
Study: 2253658

Group type: EXPERIMENTAL
Intervention: Furosemide 20 mg injected intravenously
Number of subjects: 8

Group type: COMPARATOR
Intervention: Captopril pretreatment
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Furosemide
Number of subjects: 8
Study: 7011279

Group type: EXPERIMENTAL
Intervention: Cimetidine (1.0 g/day initially, increased to 1.6 g/day if less than 50% reduction in ulcer size)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Cimetidine (600 mg/day)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Cimetidine (after stopping maintenance treatment)
Number of subjects: 14
Study: 31418331

Group type: EXPERIMENTAL
Intervention: Weight Loss group (WL)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Weight Stable group (WS)
Number of subjects: 20
Study: 30924166

Group type: EXPERIMENTAL
Intervention: Furosemide 20 mg intravenously
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo intravenously
Number of subjects: 80
Study: 28347540

Group type: EXPERIMENTAL
Intervention: Sivelestat administered perioperatively for 5 days
Number of subjects: 130

Group type: COMPARATOR
Intervention: No medications administered (Control group)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Preoperative partial pressure oxygen level
Number of subjects: 130
Study: 25864870

Group type: EXPERIMENTAL
Intervention: Vitamin D + omega-3 PUFA (30 µg vitamin D3, 3000 mg eicosapentaenoic acid, 3000 mg docosahexaenoic acid)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: COMPARATOR
Intervention: Usual diet
Number of subjects: 10
Study: 22626630

Group type: EXPERIMENTAL
Intervention: Hilotherm(®) cooling face mask
Number of subjects: 32

Group type: COMPARATOR
Intervention: Conventional cooling with cooling compresses
Number of subjects: 32
Study: 21156702

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil and low-molecular-weight heparin
Number of subjects: 615

Group type: EXPERIMENTAL
Intervention: Repeat retinal detachment surgery
Number of subjects: 615

Group type: EXPERIMENTAL
Intervention: PVR
Number of subjects: 615
Study: 19717506

Group type: EXPERIMENTAL
Intervention: Low-frequency sound wave therapy, 3-5 times a week for 30 minutes per session over 6 months
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Low-frequency sound wave therapy
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 49
Study: 17451140

Group type: EXPERIMENTAL
Intervention: Antihypertensive drugs, specifically blockers of the renin-angiotensin axis
Number of subjects: 0
Study: 15043563

Group type: EXPERIMENTAL
Intervention: WBC-reduced RBCs after implementation of ULR (T2)
Number of subjects: 2095

Group type: COMPARATOR
Intervention: Non-WBC-reduced RBCs before implementation of ULR (T1)
Number of subjects: 2095
Study: 11765303

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dofetilide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sotalol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 9323820

Group type: EXPERIMENTAL
Intervention: Warm continuous retrograde blood cardioplegia
Number of subjects: 29

Group type: COMPARATOR
Intervention: Intermittent cold retrograde blood cardioplegia
Number of subjects: 29
Study: 8313326

Group type: EXPERIMENTAL
Intervention: Conservative surgery plus radiation therapy
Number of subjects: 142

Group type: COMPARATOR
Intervention: Mastectomy
Number of subjects: 142
Study: 3046826

Group type: EXPERIMENTAL
Intervention: Piroxicam, 20 mg per day
Number of subjects: 252

Group type: COMPARATOR
Intervention: Naproxen, 750 mg per day
Number of subjects: 252
Study: 29687457

Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (CBT), 10-session manualized intervention
Number of subjects: 68

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 68
Study: 28063865

Group type: EXPERIMENTAL
Intervention: CSD SBML intervention
Number of subjects: 20
Study: 25389641

Group type: EXPERIMENTAL
Intervention: Current smoking
Number of subjects: 534

Group type: EXPERIMENTAL
Intervention: Diastolic blood pressure
Number of subjects: 534

Group type: EXPERIMENTAL
Intervention: Diabetes mellitus
Number of subjects: 534

Group type: EXPERIMENTAL
Intervention: Baseline AAA diameter
Number of subjects: 534
Study: 23692516

Group type: EXPERIMENTAL
Intervention: ICA-105665 100 mg
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: ICA-105665 400 mg
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: ICA-105665 500 mg
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 20697044

Group type: EXPERIMENTAL
Intervention: 450 or 900 mg of idebenone per day (n = 22)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: 1350 or 2250 mg of idebenone per day (n = 24)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo (n = 24)
Number of subjects: 70
Study: 18054934

Group type: EXPERIMENTAL
Intervention: ASA+Pred (n = 97)
Number of subjects: 395

Group type: COMPARATOR
Intervention: Control (n = 298)
Number of subjects: 395
Study: 16642604

Group type: EXPERIMENTAL
Intervention: Electroacupuncture at Baliao and Huiyang (BL 35)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Electroacupuncture at routinely selected acupoints (Control)
Number of subjects: 84
Study: 12855298

Group type: EXPERIMENTAL
Intervention: Information reduction tasks (digit reversal, digit classification, counting backward by 3s)
Number of subjects: 0
Study: 10807098

Group type: EXPERIMENTAL
Intervention: Hyaluronan injections
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo injection
Number of subjects: 46
Study: 9387366

Group type: EXPERIMENTAL
Intervention: Acupuncture at Zusanli (ST 36) and Neiguan (PC 6) combined with epidural anesthesia of small dosage (group A)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Simple epidural anesthesia of small dosage (group B)
Number of subjects: 48
Study: 15374380

Group type: EXPERIMENTAL
Intervention: Amantadine (200 mg for 1 h)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 3881014

Group type: EXPERIMENTAL
Intervention: Cimetidine 1800 mg/day
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sucralfate 8 g/day
Number of subjects: 20
Study: 30585829

Group type: EXPERIMENTAL
Intervention: Renal replacement therapy
Number of subjects: 1124

Group type: EXPERIMENTAL
Intervention: Platelet decrease following renal replacement therapy initiation
Number of subjects: 1124

Group type: COMPARATOR
Intervention: Continuous renal replacement therapy
Number of subjects: 1124
Study: 28456425

Group type: EXPERIMENTAL
Intervention: Spoken information supported by a leaflet
Number of subjects: 178

Group type: COMPARATOR
Intervention: Spoken information
Number of subjects: 178
Study: 26197029

Group type: EXPERIMENTAL
Intervention: 15 mg of terbutaline (TER)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 9
Study: 24988121

Group type: EXPERIMENTAL
Intervention: lisdexamfetamine dimesylate (Vyvanse)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 23080528

Group type: EXPERIMENTAL
Intervention: Integrative Body‐Mind‐Spirit (I‐BMS) intervention
Number of subjects: 339

Group type: COMPARATOR
Intervention: No-intervention control
Number of subjects: 339
Study: 19281718

Group type: EXPERIMENTAL
Intervention: Intention to treat analysis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Informative censoring
Number of subjects: 0
Study: 17227746

Group type: EXPERIMENTAL
Intervention: Homeopathic treatment (optimal medication identified after screening phase)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Homeopathic treatment (optimal medication identified)
Number of subjects: 83
Study: 15176988

Group type: EXPERIMENTAL
Intervention: Alendronate 10 mg daily plus elemental calcium 500 mg daily
Number of subjects: 55

Group type: COMPARATOR
Intervention: Calcium 500 mg daily alone
Number of subjects: 55
Study: 12351277

Group type: EXPERIMENTAL
Intervention: Resistive heating blankets
Number of subjects: 24

Group type: COMPARATOR
Intervention: Normal wool blankets
Number of subjects: 24
Study: 9839093

Group type: EXPERIMENTAL
Intervention: Acarbose (25-100 mg t.i.d.)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8208469

Group type: EXPERIMENTAL
Intervention: Teicoplanin prophylaxis
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control (no antibiotic prophylaxis)
Number of subjects: 38
Study: 2543048

Group type: EXPERIMENTAL
Intervention: New less toxic treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 0
Study: 29895740

Group type: EXPERIMENTAL
Intervention: AAR + counseling
Number of subjects: 327

Group type: COMPARATOR
Intervention: AAR + control (nutrition education attention control)
Number of subjects: 327
Study: 27440796

Group type: EXPERIMENTAL
Intervention: Polyester containing herbal extract dressing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Commercially available and common use dressings
Number of subjects: 0
Study: 24075291

Group type: EXPERIMENTAL
Intervention: Quick Mild Cognitive Impairment (Qmci) screen
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: Standardized Alzheimer's Disease Assessment Scale-cognitive section (SADAS‐cog)
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: Clinical Dementia Rating (CDR) scale
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: Lawton‐Brady activities of daily living (ADL) scale
Number of subjects: 406
Study: 23745636

Group type: EXPERIMENTAL
Intervention: Home-based HIV testing intervention
Number of subjects: 0
Study: 21169060

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus cetuximab with first-cycle rash
Number of subjects: 518

Group type: EXPERIMENTAL
Intervention: Chemotherapy plus cetuximab without first-cycle rash
Number of subjects: 518
Study: 18794757

Group type: EXPERIMENTAL
Intervention: Anterior spinal fusion (ASF) with single solid rod and single screw constructs
Number of subjects: 32

Group type: COMPARATOR
Intervention: Posterior spinal fusion (PSF) with segmental total pedicle screw system
Number of subjects: 32
Study: 17062685

Group type: EXPERIMENTAL
Intervention: Docetaxel and Vinorelbine (DV)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Docetaxel and Estramustine (DE)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: ABCG2 421 C > A (Q141K) polymorphism
Number of subjects: 64
Study: 12712781

Group type: EXPERIMENTAL
Intervention: Alveolar recruitment strategy (ARS)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (standardized mechanical ventilation)
Number of subjects: 24
Study: 11107075

Group type: EXPERIMENTAL
Intervention: Primary Closure (PC)
Number of subjects: 399

Group type: COMPARATOR
Intervention: PTFE Patch Closure
Number of subjects: 399

Group type: COMPARATOR
Intervention: PTFE Patch Closure and Vein Patch Closure (VPC)
Number of subjects: 399

Group type: COMPARATOR
Intervention: Normal Duplex Scan Findings at 6 Months (Patched Arteries)
Number of subjects: 399